Search Results - "Samoto, Vivian Yochiko"
-
1
Reduction in skeletal muscle fibrosis of spontaneously hypertensive rats after laceration by microRNA targeting angiotensin II receptor
Published in PloS one (23-10-2017)“…Regeneration of injured skeletal muscles is affected by fibrosis, which can be improved by the administration of angiotensin II (AngII) receptor (ATR) blockers…”
Get full text
Journal Article -
2
Mesenchymal stem cells do not prevent antibody responses against human α-L-iduronidase when used to treat mucopolysaccharidosis type I
Published in PloS one (18-03-2014)“…Mucopolysaccharidosis type I (MPSI) is an autosomal recessive disease that leads to systemic lysosomal storage, which is caused by the absence of…”
Get full text
Journal Article -
3
Treatment of mouse limb ischemia with an integrative hypoxia-responsive vector expressing the vascular endothelial growth factor gene
Published in PloS one (21-03-2012)“…Constitutive vascular endothelial growth factor (VEGF) gene expression systems have been extensively used to treat peripheral arterial diseases, but most of…”
Get full text
Journal Article -
4
Marsupial morphology of reproduction: South America opossum male model
Published in Microscopy research and technique (01-04-2013)“…ABSTRACT This study aims to describe the morphology of Didelphis sp. male genital organs (penis, testes, epididymis, ductus deferens, prostate, and…”
Get full text
Journal Article -
5
Synergistic effect of vascular endothelial growth factor and granulocyte colony-stimulating factor double gene therapy in mouse limb ischemia
Published in The journal of gene medicine (01-03-2010)“…Background Vascular endothelial growth factor (VEGF) has mostly been tested to treat ischemic diseases, although the outcomes obtained are not satisfactory…”
Get full text
Journal Article -
6
Granulocyte-macrophage colony-stimulating factor gene based therapy for acute limb ischemia in a mouse model
Published in The journal of gene medicine (01-04-2009)“…Background Granulocyte‐colony‐stimulating factor (GM‐CSF) is a pleiotropic factor for hematopoiesis that stimulates myeloblasts, monoblasts and mobilization of…”
Get full text
Journal Article -
7
Regenerative effect of platelet-rich plasma in the murine ischemic limbs
Published in Life sciences (1973) (01-11-2021)“…The purpose of this study was to investigate the effect of PPRP (pure PRP) and LPRP (PRP with leukocytes) on recovery from limb ischemia and on expression of…”
Get full text
Journal Article -
8
Tributyltin Impairs the Reproductive Cycle in Female Rats
Published in Journal of Toxicology and Environmental Health, Part A (15-08-2012)“…Triorganotins are environmental contaminants, commonly used in antifouling agents for boats, that bioaccumulate and thus are found in mammals and humans due to…”
Get full text
Journal Article -
9
Tributyltin Impairs the Coronary Vasodilation Induced by 17β-Estradiol in Isolated Rat Heart
Published in Journal of Toxicology and Environmental Health, Part A (15-08-2012)“…Triorganotins, such as tributyltin (TBT), are environmental contaminants that are commonly used as antifouling agents for boats. However, TBT is also known to…”
Get full text
Journal Article -
10
[alpha]- l-iduronidase gene-based therapy using the phiC31 system to treat mucopolysaccharidose type I mice
Published in The journal of gene medicine (01-01-2015)“…Background Mucopolysaccharidose type I (MPSI) is a lysosomal monogenic disease caused by mutations in the gene for [alpha]- l-iduronidase (IDUA). MPSI patients…”
Get full text
Journal Article -
11
Mesenchymal Stem Cells Do Not Prevent Antibody Responses against Human [alpha]-L-Iduronidase when Used to Treat Mucopolysaccharidosis Type I
Published in PloS one (18-03-2014)“…Mucopolysaccharidosis type I (MPSI) is an autosomal recessive disease that leads to systemic lysosomal storage, which is caused by the absence of…”
Get full text
Journal Article -
12
α- l-iduronidase gene-based therapy using the phiC31 system to treat mucopolysaccharidose type I mice
Published in The journal of gene medicine (01-01-2015)“…Background Mucopolysaccharidose type I (MPSI) is a lysosomal monogenic disease caused by mutations in the gene for α‐ l‐iduronidase (IDUA). MPSI patients need…”
Get full text
Journal Article -
13
α- l -iduronidase gene-based therapy using the phiC31 system to treat mucopolysaccharidose type I mice: Gene therapy to treat MPSI
Published in The journal of gene medicine (01-01-2015)Get full text
Journal Article -
14
Tributyltin Impairs the Coronary Vasodilation Induced by 17[Beta]-Estradiol in Isolated Rat Heart
Published in Journal of toxicology and environmental health. Part A (15-08-2012)“…Triorganotins, such as tributyltin (TBT), are environmental contaminants that are commonly used as antifouling agents for boats. However, TBT is also known to…”
Get full text
Journal Article -
15
Mesenchymal Stem Cells Do Not Prevent Antibody Responses against Human alpha -L-Iduronidase when Used to Treat Mucopolysaccharidosis Type I: e92420
Published in PloS one (01-03-2014)“…Mucopolysaccharidosis type I (MPSI) is an autosomal recessive disease that leads to systemic lysosomal storage, which is caused by the absence of alpha…”
Get full text
Journal Article -
16
Opossum (Didelphis sp) mammary gland morphology associated to the marsupial model
Published in Biota neotropica (01-01-2006)“…Vertebrates with short period of pregnancy, the marsupials tend to have small and dependent younglitters. The period of pregnancy varies of 14-15 days and, the…”
Get full text
Journal Article -
17
Morfologia da glândula mamária de gambás da espécie Didelphis sp associada ao modelo marsupial
Published in Biota neotropica (2006)“…Vertebrados com períodos gestacionais curtos, os marsupiais tendem a ter proles pequenas e dependentes. O período gestacional dos gambás varia de 14-15dias e…”
Get full text
Journal Article